Starts in 1 week from now
Locationonline
ProgrammesThe IMPETUS project, co-funded by the EU, has two open calls for Citizen Science projects i.e. the European Union Prize for Citizen Science and the IMPETUS Accelerator Programme. The webinar will provide information on the two calls and a Q&A session.
Registration for the webinar is required here. The recording of the previous webinar is available here.
What is the European Union Prize for Citizen Science?
The European Union Prize for Citizen Science invites submissions from a diverse range of initiatives that demonstrate outstanding examples of both citizens engaging with science and research, and scientists and researchers engaging with society. An initiative could consist of a project, a series of projects, an activity, or series of activities.
The Prize consists of a Grand Prize of €60,000, as well as two additional prizes to projects that best demonstrate how citizen science can be used to promote Diversity and Collaboration and Digital Communities, both of which will be awarded €20,000, and 27 projects will receive honorary mentions and will be showcased alongside the three prize winners.
The submission deadline for the European Union Prize for Citizen Science is 10 March 2025 (23:59 CET).
More information on the European Union Prize for Citizen Science 2025 Open call
What is the IMPETUS Accelerator Programme?
The IMPETUS Accelerator Programme supports new and ongoing projects which for this call need to focus on either of the following challenges: Challenge 1 Citizen Science for Circular Communities; Challenge 2 Citizen Science for a Fair and Just Society. Successful applicants will receive funding and support to deliver a seven-month project. Projects can apply for two kinds of grants, depending on their current development stage:
It is expected these grants to be awarded for the continuation, enhancing of impact, and/or further establishment of existing projects.
The submission deadline for the IMPETUS Accelerator Programme is 13 March 2025 (12:00 CET).
More information on the IMPETUS Accelerator Programme Open call.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.